FASTURTEC

Google image searchProduct monograph

Active ingredient

rasburicase, 1.5 MG/VIAL

DIN: 02248416

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 03-NOV-2006

ATC:

• V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
• V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
• V03AF — Detoxifying agents for antineoplastic treatment (ATC, ATC/DDD)
• V03AF07 — RASBURICASE (ATC/DDD)

Reference brand drug: Fasturtec

External Links for Fasturtec

Search on Google

• Fasturtec side effects
• Fasturtec dosage
• rasburicase side effects
• rasburicase dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find fasturtec photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.